SPARC expression at the RNA and protein levels was first assessed in the BM (primary lymphoid) and tonsillar (secondary lymphoid) tissues of control subjects before investigating its correlation with MM parameters and therapeutic response. Here, SPARC is linked to Miyoshi myopathy.